An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma
Zhejiang University
Zhejiang University
Northwestern University
Case Comprehensive Cancer Center
University of Alabama at Birmingham